Overview

Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents

Status:
Unknown status

Trial end date:
2019-04-01

Target enrollment:

Participant gender:

Summary

The study objective was to evaluate the intraocular pressure (IOP) lowering effect of two iStent devices in eyes of subjects with primary open-angle glaucoma, washed out of two anti-glaucoma medications (one a Prostaglandin) prior to stent implantation.

Phase:

Phase 4

Details

Lead Sponsor:

Glaukos Corporation

Treatments:

Antihypertensive Agents
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Tobramycin
Travoprost